Finding 619656 (2022-001)

Significant Deficiency
Requirement
M
Questioned Costs
-
Year
2022
Accepted
2023-06-26

AI Summary

  • Core Issue: There is a significant deficiency in internal controls related to compliance with contract requirements for subrecipients.
  • Impacted Requirements: Contracts did not include necessary disclosures as mandated by 2 CFR 200.332.
  • Recommended Follow-Up: Update all contracts with subrecipients to ensure they include the required language.

Finding Text

2022-001: Considered a significant deficiency in internal control over compliance/immaterial non-compliance Program: ALN 93.958 Block Grants for Prevention and Treatment of Substance Abuse (Treatment and Access Management) Criteria: As detailed by 2 CFR 200.332, the pass-through entity must communicate specific information to subrecipients, as applicable. Condition: During testing of contracts with subrecipients it was noted that these contracts did not include portions of required disclosures. Cause/Effect: This condition appears to be the result of inconsistent application of internal controls over compliance. Contracts with subrecipients were not in compliance with 2 CFR 200.332. Questioned Cost: None. Recommendation: We recommend that the Entity update all contracts with subrecipients to include required language. View of Responsible Official: Management is in agreement with this recommendation.

Categories

Subrecipient Monitoring Internal Control / Segregation of Duties Significant Deficiency

Other Findings in this Audit

  • 43213 2022-002
    Significant Deficiency
  • 43214 2022-001
    Significant Deficiency
  • 619655 2022-002
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.958 Block Grants for Community Mental Health Services $160,864
93.959 Block Grants for Prevention and Treatment of Substance Abuse $143,191
93.788 Opioid Str $38,652